International Flavors & Fragrances vs L3Harris
Side-by-side comparison of AI visibility scores, market position, and capabilities
New York specialty ingredients (NYSE: IFF) at $11.48B 2024 net sales, EBITDA +16%; flavors/fragrances + N&B health/biosciences ($26B 2021 acquisition), 2025 guidance 1-4% growth competing with Givaudan and dsm-firmenich.
About
International Flavors & Fragrances Inc. (IFF) is a New York City, New York-based global specialty ingredients company — publicly traded on the New York Stock Exchange (NYSE: IFF) as an S&P 500 Materials component — creating and manufacturing flavors, fragrances, enzymes, probiotics, food ingredients, cosmetic actives, and pharmaceutical excipients for consumer goods companies, food manufacturers, beverage companies, and pharmaceutical firms through approximately 20,000 employees in 110 countries. In fiscal year 2024, IFF reported net sales of $11.48 billion and adjusted operating EBITDA growth of 16% to $2.21 billion, demonstrating improved profitability following the challenging integration of the DuPont Nutrition & Biosciences business (acquired 2021 for ~$26 billion in the largest transaction in IFF's history). For 2025, IFF guided 1-4% comparable currency-neutral sales growth, with continued margin improvement as the integration synergies are realized. CEO Jon Erik Fyrwald leads the company through its integration and portfolio optimization phase. IFF operates across four segments: Nourish (flavors, functional ingredients, proteins, food and beverage innovation), Scent (fine fragrances, consumer fragrances, cosmetic actives), Health & Biosciences (enzymes, microbiome, probiotics, animal nutrition), and Pharma Solutions (pharmaceutical excipients and delivery systems) — serving every major category of consumer products from food and beverages to personal care, household products, and medicine.
Melbourne FL defense electronics (NYSE: LHX) $21.3B FY2024 revenue (+8%); tactical radios, ISR, electronic warfare, JADC2 networks, Falcon radio family competing with Raytheon and Northrop Grumman.
About
L3Harris Technologies, Inc. is a Melbourne, Florida-based defense electronics and technology company — publicly traded on the New York Stock Exchange (NYSE: LHX) as an S&P 500 Industrials component — providing advanced defense electronics, intelligence, surveillance and reconnaissance (ISR) systems, communication systems, and aviation products for US and allied defense forces through approximately 47,000 employees across four segments: Integrated Mission Systems (ISR aircraft modifications, electro-optical/infrared systems, maritime patrol aircraft), Space & Airborne Systems (military satellite communications, electronic warfare, precision weapons guidance), Communication Systems (tactical radio communications, night vision devices, public safety communications), and Aerojet Rocketdyne (integrated into L3Harris via investment, pending completion). L3Harris Technologies was formed in June 2019 through the merger of L3 Technologies and Harris Corporation — combining Harris's radio communication and space systems expertise with L3's ISR sensors, aircraft modification, and training systems capabilities to create the sixth-largest US defense contractor by revenue. In fiscal year 2024, L3Harris reported revenues of $21.3 billion (+8% year-over-year), with strong growth driven by JADC2 (Joint All-Domain Command and Control) radio and network programs, F-35 avionics subsystems production, and international NATO ally military communication equipment demand. CEO Christopher Kubasik has focused on margin improvement and portfolio optimization — divesting non-core businesses (commercial aviation training — sold Pilot Training business, Link Simulation & Training to CAE) while investing R&D in the electronic warfare (EW) and space domain awareness capabilities where L3Harris holds differentiated technology advantages.
AI Visibility Head-to-Head
Key Details
Also Compare
International Flavors & Fragrances vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.